Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacotherapy: Pasireotide shows promise for the treatment of acromegaly.

Literature DB >> 20681073

Pharmacotherapy: Pasireotide shows promise for the treatment of acromegaly.

Carol Wilson.

Abstract

Entities: Disease

Year: 2010 PMID： 20681073 DOI： 10.1038/nrendo.2010.99

Source DB: PubMed Journal: Nat Rev Endocrinol ISSN： 1759-5029 Impact factor: 43.330

× No keyword cloud information.

1 in total

1. Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial.

Authors: S Petersenn; J Schopohl; A Barkan; P Mohideen; A Colao; R Abs; A Buchelt; Y-Y Ho; K Hu; A J Farrall; S Melmed; B M K Biller
Journal: J Clin Endocrinol Metab Date: 2010-04-21 Impact factor: 5.958

1 in total

3 in total

Review 1. Management options for persistent postoperative acromegaly.

Authors: Nestoras Mathioudakis; Roberto Salvatori
Journal: Neurosurg Clin N Am Date: 2012-08-09 Impact factor: 2.509

Review 2. Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.

Authors: Maria Fleseriu
Journal: Pituitary Date: 2011-06 Impact factor: 4.107

3. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST₅ ) in pituitary and pancreatic neuroendocrine tumors.

Authors: Sergio Pedraza-Arevalo; Alejandro Ibáñez-Costa; Ricardo Blázquez-Encinas; Miguel R Branco; Mari C Vázquez-Borrego; Aura D Herrera-Martínez; Eva Venegas-Moreno; Raquel Serrano-Blanch; Álvaro Arjona-Sánchez; María A Gálvez-Moreno; Marta Korbonits; Alfonso Soto-Moreno; Manuel D Gahete; Marika Charalambous; Raúl M Luque; Justo P Castaño
Journal: Mol Oncol Date: 2021-10-26 Impact factor: 6.603